These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33802238)

  • 1. Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Chariyakornkul A; Suzuki S; Khuanphram N; Tatsumi K; Yamano S; Fujioka M; Gi M; Wongpoomchai R; Wanibuchi H
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
    Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
    Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice.
    Iida A; Kuranuki S; Yamamoto R; Uchida M; Ohta M; Ichimura M; Tsuneyama K; Masaki T; Seike M; Nakamura T
    Exp Anim; 2019 Nov; 68(4):417-428. PubMed ID: 31155606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.
    Kakehashi A; Stefanov VE; Ishii N; Okuno T; Fujii H; Kawai K; Kawada N; Wanibuchi H
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological analysis of the progression of hepatic lesions in STAM mice.
    Saito T; Muramatsu M; Ishii Y; Saigo Y; Konuma T; Toriniwa Y; Miyajima K; Ohta T
    Physiol Res; 2017 Nov; 66(5):791-799. PubMed ID: 28730823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy with expression of NADPH oxidase subunit p22phox in preneoplastic lesions in a high-fat diet and streptozotocin-related hepatocarcinogenesis rat model.
    Ichikawa R; Masuda S; Nakahara J; Kobayashi M; Yamashita R; Uomoto S; Kanami O; Hara E; Ito Y; Shibutani M; Yoshida T
    J Toxicol Sci; 2022; 47(7):289-300. PubMed ID: 35786680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.
    Kawai D; Takaki A; Nakatsuka A; Wada J; Tamaki N; Yasunaka T; Koike K; Tsuzaki R; Matsumoto K; Miyake Y; Shiraha H; Morita M; Makino H; Yamamoto K
    Hepatology; 2012 Sep; 56(3):912-21. PubMed ID: 22505328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Administration of Mulberry (
    Wakame K; Sato K; Kasai M; Kikuchi E; Shimizu K; Kudo A; Komatsu KI; Nakata A
    Anticancer Res; 2022 Aug; 42(8):4055-4062. PubMed ID: 35896224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
    Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
    Jojima T; Wakamatsu S; Kase M; Iijima T; Maejima Y; Shimomura K; Kogai T; Tomaru T; Usui I; Aso Y
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
    Kakehashi A; Kato A; Inoue M; Ishii N; Okazaki E; Wei M; Tachibana T; Wanibuchi H
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):47-55. PubMed ID: 19796649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis.
    Saito K; Uebanso T; Maekawa K; Ishikawa M; Taguchi R; Nammo T; Nishimaki-Mogami T; Udagawa H; Fujii M; Shibazaki Y; Yoneyama H; Yasuda K; Saito Y
    Sci Rep; 2015 Aug; 5():12466. PubMed ID: 26289793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canopy Homolog 2 as a Novel Molecular Target in Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Shiota M; Raymo N; Gi M; Tachibana T; Stefanov V; Wanibuchi H
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of autophagosome markers LC3 and p62 in preneoplastic liver foci in high fat diet-fed rats.
    Masuda S; Mizukami S; Eguchi A; Ichikawa R; Nakamura M; Nakamura K; Okada R; Tanaka T; Shibutani M; Yoshida T
    J Toxicol Sci; 2019; 44(8):565-574. PubMed ID: 31378768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
    Sagawa H; Naiki-Ito A; Kato H; Naiki T; Yamashita Y; Suzuki S; Sato S; Shiomi K; Kato A; Kuno T; Matsuo Y; Kimura M; Takeyama H; Takahashi S
    Carcinogenesis; 2015 Dec; 36(12):1539-49. PubMed ID: 26494227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis.
    Sumi T; Shirakami Y; Shimizu M; Kochi T; Ohno T; Kubota M; Shiraki M; Tsurumi H; Tanaka T; Moriwaki H
    Springerplus; 2013; 2():690. PubMed ID: 25674420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment and evaluation of a mouse model of nonalcoholic steatohepatitis-related hepatocellular carcinoma].
    Luo Y; Yang WJ; Chen JY; Zhang J; Zeng XD; Zhuang ZJ; Zang SF; Zhou G; Di CH; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):279-84. PubMed ID: 27470627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis.
    Romualdo GR; Silva EDA; Da Silva TC; Aloia TPA; Nogueira MS; De Castro IA; Vinken M; Barbisan LF; Cogliati B
    Environ Toxicol; 2020 Apr; 35(4):518-527. PubMed ID: 31804025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.